[Letter: Management of hyperkalemia during necessary spironolactone administration].
D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced / Q000188:drug therapy*; D007475:Ion Exchange Resins / Q000627:therapeutic use; D013148:Spironolactone / Q000009:adverse effects*
D007475:Ion Exchange Resins; D013148:Spironolactone
Zur Beeinflussung der Hyperkaliämie unter notwendiger Spironolacton-Medikation